A
NYSE
Life Sciences Tools & Services
$132.86
USD
+$2.60 (+2.00%)
At close: Jul 21, 2026, 4:00 PM EDT
Market Cap:
$37.39B
Volume:
2.4M
Previous Close
$130.26
Day Range
$125.00 - $134.78
52 Week Range
$108.35 - $160.27
Average Volume (10 Days)
2.3M
P/E Ratio (TTM)
26.44
Dividend Yield
0.76%
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. The company is headquartered in Santa Clara, California and currently employs 18,000 full-time employees. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.
CEO
Mr. Padraig McDonnell
Headquaters
Santa Clara, CALIFORNIA, US
Founded
1999
Employees
18,000
Agilent Technologies received a 'buy' upgrade from Bank of America following its impressive second-quarter fiscal 2026 results. The company exceeded revenue guidance with 6.3% core growth to $1.83 billion, while net income surged 58% to $339 million. The strong performance reflects operational improvements and innovation-driven market share gains.
0
0
WST
West Pharmaceutical Services Inc
$359.24
+2.0%
WAT
Waters Corp
$367.55
+2.8%